We are live on
!
Find out more
Schroder Investment Management Group Portfolio holdings
AUM
$122B
1-Year Est. Return
29.27%
This Fund
S&P 500
This Quarter
Est. Return
+1.74%
1 Year Est. Return
+29.27%
3 Year Est. Return
+98.87%
5 Year Est. Return
+131.84%
10 Year Est. Return
+513.68%
AUM
$37.8B
AUM Growth
–
Cap. Flow
+$38.1B
Cap. Flow
% of AUM
100.76%
Top 10 Holdings %
Top 10 Hldgs %
12.48%
Holding
1,431
New
1,431
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$613M |
| 2 |
Microsoft
MSFT
|
+$558M |
| 3 |
Itaú Unibanco
ITUB
|
+$507M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$492M |
| 5 |
Suncor Energy
SU
|
+$423M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.2% |
| 2 | Healthcare | 13.94% |
| 3 | Technology | 12.07% |
| 4 | Industrials | 9.76% |
| 5 | Energy | 8.29% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
WP
176
DELISTED
Worldpay, Inc.
WP
| $53.7M | 0.14% |
+1,943,905
| New | +$48.1M |
|
177
Children's Place
PLCE
$59.8M
| $53.4M | 0.14% |
+974,740
| New | +$49.2M |
|
178
Canadian National Railway
CNI
$76.6B
| $53.4M | 0.14% |
+1,100,136
| New | +$54.3M |
|
179
United Therapeutics
UTHR
$23.1B
| $53.3M | 0.14% |
+809,921
| New | +$52.2M |
|
|
SLXP
180
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
| $52.8M | 0.14% |
+798,200
| New | +$45.6M |
|
181
HF Sinclair
DINO
$14.5B
| $52.8M | 0.14% |
+1,233,368
| New | +$58.9M |
|
|
PRE
182
DELISTED
PARTNERRE LTD
PRE
| $52.7M | 0.14% |
+581,715
| New | +$52.9M |
|
|
SYA
183
DELISTED
SYMETRA FINANCIAL CORPORATION COMMON STOCK
SYA
| $52.4M | 0.14% |
+3,278,742
| New | +$45.8M |
|
|
SEE
184
DELISTED
Sealed Air
SEE
| $52.2M | 0.14% |
+2,180,051
| New | +$50.3M |
|
185
Magna International
MGA
$18.8B
| $52.2M | 0.14% |
+1,471,474
| New | +$46.6M |
|
|
BYI
186
DELISTED
BALLY TECHNOLOGIES, INC.
BYI
| $52M | 0.14% |
+921,050
| New | +$49.3M |
|
|
WCN
187
Waste Connections
WCN
$42B
| $51.8M | 0.14% |
+1,888,767
| New | +$48.5M |
|
188
Leidos
LDOS
$17.3B
| $51.5M | 0.14% |
+1,497,616
| New | +$53.2M |
|
189
KLA
KLAC
$259B
| $50.7M | 0.13% |
+9,096,990
| New | +$49.7M |
|
190
Norfolk Southern
NSC
$75.1B
| $50.1M | 0.13% |
+689,513
| New | +$52.6M |
|
|
SFG
191
DELISTED
STANCORP FINL GRP
SFG
| $49.9M | 0.13% |
+1,009,694
| New | +$44.6M |
|
192
Chemed
CHE
$7.22B
| $49.3M | 0.13% |
+680,339
| New | +$49.9M |
|
|
XEC
193
DELISTED
CIMAREX ENERGY CO
XEC
| $49.2M | 0.13% |
+757,002
| New | +$53.8M |
|
|
LLL
194
DELISTED
L3 Technologies, Inc.
LLL
| $48.7M | 0.13% |
+568,267
| New | +$47.6M |
|
|
LIFE
195
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
| $48.3M | 0.13% |
+652,592
| New | +$47.4M |
|
|
KRFT
196
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| $48.3M | 0.13% |
+864,352
| New | +$46.4M |
|
|
GDI
197
DELISTED
GARDNER DENVER,INC
GDI
| $48.2M | 0.13% |
+641,200
| New | +$48.2M |
|
198
T. Rowe Price
TROW
$24.3B
| $48.2M | 0.13% |
+657,812
| New | +$49.1M |
|
199
Ultrapar
UGP
$6.54B
| $47.4M | 0.13% |
+3,961,810
| New | +$50.7M |
|
|
AMSG
200
DELISTED
Amsurg Corp
AMSG
| $47.1M | 0.12% |
+1,342,836
| New | +$46.6M |
|
Similar funds
VAM
Schroder Investment Management Group's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Schroder Investment Management Group, which disclosed 1,431 positions worth $37.8B. Its ten largest holdings account for 12% of the portfolio.
Its largest position is Pfizer: 22,181,689 shares worth $589M.
By sector, the portfolio is most concentrated in Financials at 16% of assets, followed by Healthcare and Technology.
- Schroder Investment Management Group's largest Q2 2013 buy was Pfizer: 22,181,689 shares worth $589M.
- Schroder Investment Management Group's ten largest holdings make up 12% of its $37.8B portfolio in Q2 2013.
- Schroder Investment Management Group disclosed 1,431 positions in Q2 2013, its first 13F filing on record.
Based on Schroder Investment Management Group's 13F filing for Q2 2013, filed 12 Aug 2013.